For the first time in 40 years, the US Toxic Substances Control Act (TSCA) has been revised, with the new law making it simpler for the EPA to regulate harmful chemicals. Since the creation of the TSCA in 1976, the EPA has regulated only five chemicals, likely due to the limited amount of time the […]
In 2015, spending on cancer medicines reached $107 billion, an 11.5% increase in constant dollars. Globally, over 500 companies are focusing on oncology development, with 511 companies pursuing a Late Phase active pipeline and 379 firms with drugs in Phase II development. Of the 511 companies, oncology drug development made up 49% of collective R&D. […]
Bio-Rad Delivers Strong LS Results Bio-Rad Laboratories Life Science (LS) recorded nearly double-digit quarterly sales growth due to a weak comparison in China and a strong backlog, which was bolstered by system-related challenges in the third quarter of 2015. LS first quarter sales climbed 6.4% to $165.9 million to account for 35% of revenue. Excluding […]
Last month, the US government launched the public-private National Microbiome Initiative (NMI) to research microbiomes in different ecosystems. The three recommended areas of focus are: interdisciplinary research, to further understanding about the relationship between microbiomes and their ecosystems; platform technologies, to increase collaboration and access to research data; and workforce expansion, to encourage engagement in […]
Venlo, the Netherlands 5/19/16; Venlo, the Netherlands 6/8/16; Copenhagen, Denmark 6/8/16—For a third time, QIAGEN has extended its offer to acquire the outstanding shares of publicly held Exiqon (see IBO 3/31/16). The offer period has been extended to June 22, following previous deadlines of May 18 and June 2. On June 8, QIAGEN lowered the […]
London, UK 6/3/16; London, UK 6/9/16—Continental Investment Partners and Harwood Capital (the offerors) disclosed in a public filing that they are evaluating making an offer worth £62.9 million ($ 91.2 million = £0.69 = $1) for publicly held Source BioScience. Source BioScience consists of two divisions: Laboratory Services (Diagnostics, DNA Sequencing and Genomics, Analytical and […]
Skokie, IL 6/2/16; Skokie, IL 6/10/16—Integrated DNA Technologies (IDT), a provider of custom nucleic acids, has purchased two companies for undisclosed amounts. Earlier in the month, IDT purchased MBiotech, a South Korean company that has distributed IDT products for over 10 years. MBiotech also distributes other companies’ products, which it will continue to do. “MBiotech’s […]
Radnor, PA 6/2/16—Lab product, service and solutions company VWR has acquired Netherlands-based JM Separations, a provider of single-use fluid handling and separation technology, including single-use bag systems, and custom solutions for media/buffer preparation, cell harvesting, and for clarification, concentration and chromatographic processes. Financial details were not disclosed.“The acquisition will broaden VWR’s single-use product and service […]
Richmond, VA 6/9/16; New York, NY 5/13/16—Health care services and information technology firm McKesson has purchased LABSCO from Frazier Healthcare Partners for an undisclosed amount. The purchase was completed on May 13. A distributor of capital equipment and private label products, LABSCO provides lab solutions to community hospitals, large doctors’ offices and specialty regional labs. […]
In the US, dietary supplements (DS) are not required to undergo the same stringent testing, standardization and regulation as pharmaceutical drugs, leaving opportunities for DS companies to make misleading claims, mislabel packages and use contaminated ingredients. Adulteration of DS has long been a concern of consumers and regulatory bodies due to the lack of required […]
Pay Invoice
Latest Blogs
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
-
SLAS2025: Lab Automation and More
January 23, 2025 4:00 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
